Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Laboratory Corporation of America Holdings

NYSE

Market Cap.

17.75B

Avg. Volume

789.58K

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Laboratory Corporation of America Holdings!

Still processing it, give me a bit more time...

Laboratory Corporation of America Holdings News

Laboratory Corporation of America Holdings Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Diagnostics & Research
labcorp.com

About Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Laboratory Corporation of America Holdings Earnings & Revenue

Laboratory Corporation of America Holdings Financials

Table Compare

Compare LH metrics with:

   

Earnings & Growth

LH

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

LH

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

LH

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

LH

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Laboratory Corporation of America Holdings Income

Laboratory Corporation of America Holdings Balance Sheet

Laboratory Corporation of America Holdings Cash Flow

Laboratory Corporation of America Holdings Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioBuy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Laboratory Corporation of America Holdings Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.88

Payment DateDividendFrequency
2024-06-120.72Quarterly
2024-03-130.72Quarterly
2023-12-120.72Quarterly
2023-09-080.72Quarterly
2023-06-080.72Quarterly

Historical Market Cap

Shares Outstanding

Laboratory Corporation of America Holdings Executives

NameRole
Mr. Adam H. SchechterPresident, Chief Executive Officer & Chairman
Mr. Glenn A. EisenbergChief Financial Officer & Executive Vice President
Mr. Mark S. SchroederExecutive Vice President, President of Diagnostics Laboratories & Chief Operating Officer
Ms. Anita Z. GrahamExecutive Vice President & Chief Human Resources Officer
Dr. Brian J. Caveney J.D., M.D., M.P.H.EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer
NameRoleGenderDate of BirthPay
Mr. Adam H. SchechterPresident, Chief Executive Officer & ChairmanMale19654.66M
Mr. Glenn A. EisenbergChief Financial Officer & Executive Vice PresidentMale19611.87M
Mr. Mark S. SchroederExecutive Vice President, President of Diagnostics Laboratories & Chief Operating OfficerMale19611.43M
Ms. Anita Z. GrahamExecutive Vice President & Chief Human Resources OfficerFemale19711.35M
Dr. Brian J. Caveney J.D., M.D., M.P.H.EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer19741.3M

Laboratory Corporation of America Holdings Insider Trades

Date14 May
Namevan der Vaart Sandra D
RoleEVP, Chief Legal Officer
TransactionDisposed
TypeS-Sale
Shares1800
Date14 May
Namevan der Vaart Sandra D
RoleEVP, Chief Legal Officer
TransactionDisposed
TypeS-Sale
Shares200
Date30 Apr
NameANDERSON KERRII B
RoleDirector
TransactionDisposed
TypeS-Sale
Shares250
Date2 May
NameANDERSON KERRII B
RoleDirector
TransactionDisposed
TypeS-Sale
Shares250
Date30 Apr
NameEISENBERG GLENN A
RoleChief Financial Officer, EVP
TransactionAcquired
TypeM-Exempt
Shares10229
DateNameRoleTransactionTypeShares
14 Mayvan der Vaart Sandra DEVP, Chief Legal OfficerDisposedS-Sale1800
14 Mayvan der Vaart Sandra DEVP, Chief Legal OfficerDisposedS-Sale200
30 AprANDERSON KERRII BDirectorDisposedS-Sale250
2 MayANDERSON KERRII BDirectorDisposedS-Sale250
30 AprEISENBERG GLENN AChief Financial Officer, EVPAcquiredM-Exempt10229

Discover More

Streamlined Academy

Laboratory Corporation of America Holdings

NYSE

Market Cap.

17.75B

Avg. Volume

789.58K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Laboratory Corporation of America Holdings News

Laboratory Corporation of America Holdings Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Laboratory Corporation of America Holdings Earnings & Revenue

Laboratory Corporation of America Holdings Income

Laboratory Corporation of America Holdings Balance Sheet

Laboratory Corporation of America Holdings Cash Flow

Laboratory Corporation of America Holdings Financials Over Time

Laboratory Corporation of America Holdings Executives

NameRole
Mr. Adam H. SchechterPresident, Chief Executive Officer & Chairman
Mr. Glenn A. EisenbergChief Financial Officer & Executive Vice President
Mr. Mark S. SchroederExecutive Vice President, President of Diagnostics Laboratories & Chief Operating Officer
Ms. Anita Z. GrahamExecutive Vice President & Chief Human Resources Officer
Dr. Brian J. Caveney J.D., M.D., M.P.H.EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer
NameRoleGenderDate of BirthPay
Mr. Adam H. SchechterPresident, Chief Executive Officer & ChairmanMale19654.66M
Mr. Glenn A. EisenbergChief Financial Officer & Executive Vice PresidentMale19611.87M
Mr. Mark S. SchroederExecutive Vice President, President of Diagnostics Laboratories & Chief Operating OfficerMale19611.43M
Ms. Anita Z. GrahamExecutive Vice President & Chief Human Resources OfficerFemale19711.35M
Dr. Brian J. Caveney J.D., M.D., M.P.H.EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer19741.3M

Laboratory Corporation of America Holdings Insider Trades

Date14 May
Namevan der Vaart Sandra D
RoleEVP, Chief Legal Officer
TransactionDisposed
TypeS-Sale
Shares1800
Date14 May
Namevan der Vaart Sandra D
RoleEVP, Chief Legal Officer
TransactionDisposed
TypeS-Sale
Shares200
Date30 Apr
NameANDERSON KERRII B
RoleDirector
TransactionDisposed
TypeS-Sale
Shares250
Date2 May
NameANDERSON KERRII B
RoleDirector
TransactionDisposed
TypeS-Sale
Shares250
Date30 Apr
NameEISENBERG GLENN A
RoleChief Financial Officer, EVP
TransactionAcquired
TypeM-Exempt
Shares10229
DateNameRoleTransactionTypeShares
14 Mayvan der Vaart Sandra DEVP, Chief Legal OfficerDisposedS-Sale1800
14 Mayvan der Vaart Sandra DEVP, Chief Legal OfficerDisposedS-Sale200
30 AprANDERSON KERRII BDirectorDisposedS-Sale250
2 MayANDERSON KERRII BDirectorDisposedS-Sale250
30 AprEISENBERG GLENN AChief Financial Officer, EVPAcquiredM-Exempt10229

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
labcorp.com

About Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Laboratory Corporation of America Holdings!

Still processing it, give me a bit more time...

Laboratory Corporation of America Holdings Financials

Table Compare

Compare LH metrics with:

   

Earnings & Growth

LH

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

LH

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

LH

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

LH

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Laboratory Corporation of America Holdings Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.88

Payment DateDividendFrequency
2024-06-120.72Quarterly
2024-03-130.72Quarterly
2023-12-120.72Quarterly
2023-09-080.72Quarterly
2023-06-080.72Quarterly

Laboratory Corporation of America Holdings Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioBuy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More